A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- Janssen Research & Development, LLC
- Study ID
- NCT05265273
- Phase
- PHASE2/PHASE3
- Status
- Recruiting
Conditions
- Myasthenia Gravis
Eligibility Criteria
- Sex
- ALL
- Age
- 2 Years - 17 Years
- Healthy Volunteers
- Not accepted
Interventions
- Nipocalimab — DRUGNipocalimab will be administered as an IV infusion.
Study Details
The purpose of this study is to determine the effect of nipocalimab on total serum immunoglobulin G (IgG) in pediatric participants 2 to less than (\<) 18 years of age (globally) and 8 to \<18 years of age (for Unites Stated (US) sites only), the safety and tolerability of treatment with nipocalimab in children and adolescents and to evaluate the pharmacokinetics (PK) of nipocalimab in children and adolescents with generalized myasthenia gravis (gMG) who have an insufficient clinical response to ongoing, stable standard-of-care therapy.
Key Dates
- Start date
- Jul 20, 2022
- Status verified
- Mar 2026
- Primary completion
- Jun 26, 2026
- Completion
- Jul 2, 2029
Study Design
- Enrollment
- 12 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: NipocalimabParticipants age 2 to less than (\<) 18 years of age (globally) and 8 to \<18 years of age (for US sites only) will be divided into 2 cohorts as per their age-adolescents 12 to \<18 years and children 2 to \<12 years and will receive nipocalimab once every two weeks for 24 weeks. After Week 24, all participants will have the option to enroll in long term extension (LTE).
Primary Outcome Measure
Change from Baseline in Total Serum Immunoglobulin-G (IgG) Levels [ Time Frame: Up to 3 years ]
Central Contacts
- Study Contact844-434-4210
Locations (11)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Phoenix Children's Hospital | Phoenix | Arizona | 85016 | - |
| Childrens Hospital Los Angeles | Los Angeles | California | 90027 | - |
| Lucile Packard Children's Hospital Stanford | Palo Alto | California | 94304 | - |
| UCSF Benioff Children's Hospital | San Francisco | California | 94158 | - |
| Children's Hospital Colorado | Aurora | Colorado | 80045 | - |
| University of South Florida Morsani Center for Advanced Healthcare | Tampa | Florida | 33613 | - |
| University of Kansas Medical Center | Lawrence | Kansas | 66045 | - |
| C.S. Mott Children's Hospital | Ann Arbor | Michigan | 48109 | - |
| Penn State Milton S Hershey Medical Ctr | Hershey | Pennsylvania | 17033 | - |
| Childrens Hospital Of Philadelphia | Philadelphia | Pennsylvania | 19106 | - |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15224 | - |
Find similar trials in Phoenix, AZ
By research site
Phoenix Children's Hospital· Phoenix, AZChildrens Hospital Los Angeles· Los Angeles, CALucile Packard Children's Hospital Stanford· Palo Alto, CAUCSF Benioff Children's Hospital· San Francisco, CAChildren's Hospital Colorado· Aurora, COUniversity of South Florida Morsani Center for Advanced Healthcare· Tampa, FL
Related Studies
- Serum Auto-Antibodies in Neurological DiseasesEnrolling By Invitation · University of California, Davis · Sacramento, California
- A Study of Nipocalimab Administered to Adults With Generalized Myasthenia GravisPHASE3 · Recruiting · Janssen Research & Development, LLC · Paradise Valley, Arizona
- The ME&MG Digital Solution for Autonomous Assessment of Myasthenia GravisRecruiting · Ad scientiam · Aurora, Colorado
- Vitaccess Real MG RegistryRecruiting · Vitaccess Ltd · Orange, California